These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37487711)

  • 1. Admission blood eosinophil count, inpatient death and death at 1 year in exacerbating patients with COPD.
    Echevarria C; Steer J; Prasad A; Quint JK; Bourke SC
    Thorax; 2023 Nov; 78(11):1090-1096. PubMed ID: 37487711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis.
    Harries TH; Rowland V; Corrigan CJ; Marshall IJ; McDonnell L; Prasad V; Schofield P; Armstrong D; White P
    Respir Res; 2020 Jan; 21(1):3. PubMed ID: 31900184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of Blood Eosinophil Count to Exacerbations in Chronic Obstructive Pulmonary Disease.
    Zeiger RS; Tran TN; Butler RK; Schatz M; Li Q; Khatry DB; Martin U; Kawatkar AA; Chen W
    J Allergy Clin Immunol Pract; 2018; 6(3):944-954.e5. PubMed ID: 29153881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophil counts in first COPD hospitalizations: a comparison of health service utilization.
    Bélanger M; Couillard S; Courteau J; Larivée P; Poder TG; Carrier N; Girard K; Vézina FA; Vanasse A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3045-3054. PubMed ID: 30319252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial.
    Pascoe S; Barnes N; Brusselle G; Compton C; Criner GJ; Dransfield MT; Halpin DMG; Han MK; Hartley B; Lange P; Lettis S; Lipson DA; Lomas DA; Martinez FJ; Papi A; Roche N; van der Valk RJP; Wise R; Singh D
    Lancet Respir Med; 2019 Sep; 7(9):745-756. PubMed ID: 31281061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinopenia as a marker of mortality and length of stay in patients admitted with exacerbations of chronic obstructive pulmonary disease.
    Holland M; Alkhalil M; Chandromouli S; Janjua A; Babores M
    Respirology; 2010 Jan; 15(1):165-7. PubMed ID: 19947999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
    Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F
    COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts.
    Cheng SL; Lin CH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2341-2348. PubMed ID: 27703344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High eosinophil blood counts are associated with a shorter length of hospital stay in exacerbated COPD patients - a retrospective analysis.
    Greulich T; Tüffers J; Mager S; Eder A; Maxheim M; Alter P; Schmeck B; Vogelmeier CF
    Respir Res; 2020 May; 21(1):106. PubMed ID: 32375777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD.
    Song JH; Lee CH; Kim JW; Lee WY; Jung JY; Park JH; Jung KS; Yoo KH; Park YB; Kim DK
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2455-2464. PubMed ID: 28860740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis.
    Pavord ID; Lettis S; Anzueto A; Barnes N
    Lancet Respir Med; 2016 Sep; 4(9):731-741. PubMed ID: 27460163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials.
    Singh D; Wedzicha JA; Siddiqui S; de la Hoz A; Xue W; Magnussen H; Miravitlles M; Chalmers JD; Calverley PMA
    Respir Res; 2020 Sep; 21(1):240. PubMed ID: 32943047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids.
    Siddiqui SH; Pavord ID; Barnes NC; Guasconi A; Lettis S; Pascoe S; Petruzzelli S
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3669-3676. PubMed ID: 30464449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease.
    Yun JH; Lamb A; Chase R; Singh D; Parker MM; Saferali A; Vestbo J; Tal-Singer R; Castaldi PJ; Silverman EK; Hersh CP;
    J Allergy Clin Immunol; 2018 Jun; 141(6):2037-2047.e10. PubMed ID: 29709670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink.
    Landis S; Suruki R; Maskell J; Bonar K; Hilton E; Compton C
    COPD; 2018 Apr; 15(2):177-184. PubMed ID: 29558236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of exacerbations and blood eosinophils in UK and US COPD populations.
    Vogelmeier CF; Kostikas K; Fang J; Tian H; Jones B; Morgan CL; Fogel R; Gutzwiller FS; Cao H
    Respir Res; 2019 Aug; 20(1):178. PubMed ID: 31391053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between eosinophilic exacerbation and eosinophilic levels in stable COPD.
    Kang HS; Kim SK; Kim YH; Kim JW; Lee SH; Yoon HK; Rhee CK
    BMC Pulm Med; 2021 Mar; 21(1):74. PubMed ID: 33653314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood Eosinophils and Outcomes in Severe Hospitalized Exacerbations of COPD.
    Bafadhel M; Greening NJ; Harvey-Dunstan TC; Williams JE; Morgan MD; Brightling CE; Hussain SF; Pavord ID; Singh SJ; Steiner MC
    Chest; 2016 Aug; 150(2):320-8. PubMed ID: 26851799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood eosinophils and inhaled corticosteroids in patients with COPD: systematic review and meta-analysis.
    Cheng SL
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2775-2784. PubMed ID: 30233168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy.
    Benson VS; Pascoe KC; Siddall J; Small M; Müllerová H
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2711-2723. PubMed ID: 31819403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.